Analysis of 60 Reported Glioma Risk SNPs Replicates Published GWAS Findings but Fails to Replicate Associations From Published Candidate-Gene Studies

Genetic Epidemiology

Volumn 37, Issue 2, 2013, Pages 222-228

  Walsh, Kyle M ^a,b   Anderson, Erik ^a   Hansen, Helen M ^a   Decker, Paul A ^c   Kosel, Matt L ^c   Kollmeyer, Thomas ^c   Rice, Terri ^a   Zheng, Shichun ^a   Xiao, Yuanyuan ^a   Chang, Jeffrey S ^a   Mccoy, Lucie S ^a   Bracci, Paige M ^a   Wiemels, Joe L ^a   Pico, Alexander R ^d   Smirnov, Ivan ^a   Lachance, Daniel H ^c   Sicotte, Hugues ^c   Eckel Passow, Jeanette E ^c   Wiencke, John K ^a   Jenkins, Robert B ^c   Wrensch, Margaret R ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Mayo Clinic   (United States)

^d GLADSTONE INSTITUTES   (United States)

Author keywords

Candidate gene; Glioma; GWAS; SNP

Indexed keywords

CCDC26 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR; PHLDB1 PROTEIN; PROTEIN; PROTEIN P53; RTEL1 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CALIFORNIA; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA HELICASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, P16; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLIOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TELOMERASE;

EID: 84872401601     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21707     Document Type: Article

References (39)

1. Bethke L, Sullivan K, Webb E, Murray A, Schoemaker M, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC and others. 2008a. The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev 17(4):987-989.
2. Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lonn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A and others. 2008b. Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 17(5):1195-1202.
3. Bethke L, Webb E, Murray A, Schoemaker M, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P and others. 2008c. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet 17(6):800-805.
4. Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, Chanock SJ, Fine HA, Linet MS, Inskip PD. 2007. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 28(12):2543-2547.
5. Caggana M, Kilgallen J, Conroy JM, Wiencke JK, Kelsey KT, Miike R, Chen P, Wrensch MR. 2001. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev 10(4):355-360.
6. Chang JS, Yeh RF, Wiencke JK, Wiemels JL, Smirnov I, Pico AR, Tihan T, Patoka J, Miike R, Sison JD and others. 2008. Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. Cancer Epidemiol Biomarkers Prev 17(6):1368-1373.
7. Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, Kelsey K, Lee M, Liu J, Wrensch M. 2000. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 9(8):843-847.
8. Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, Marsit CJ, Wiemels JL, Nelson HH, Karagas MR, Wrensch MR and others. 2010. DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst 103(2):143-153.
9. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB. 2010. Rare variants create synthetic genome-wide associations. PLoS Biol 8(1):1-12.
10. Dobbins SE, Hosking FJ, Shete S, Armstrong G, Swerdlow A, Liu Y, Yu R, Lau C, Schoemaker MJ, Hepworth SJ and others. 2011. Allergy and glioma risk: test of association by genotype. Int J Cancer 128(7):1736-1740.
11. Dou T, Wu Q, Chen X, Ribas J, Ni X, Tang C, Huang F, Zhou L, Lu D. 2010. A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol 136(12):1853-1859.
12. Felini MJ, Olshan AF, Schroeder JC, North KE, Carozza SE, Kelsey KT, Liu M, Rice T, Wiencke JK, Wrensch MR. 2007. DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology 29(1-2):55-58.
13. Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W and others. 2009. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1, 010 diffuse gliomas. Acta Neuropathol 118(4):469-474.
14. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. 2009. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106(23):9362-9367.
15. Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, Xiao Y, Kollmeyer TM, Rynearson AL, Fink S, Rice T and others. 2011. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 204(1):13-18.
16. Jenkins RB, Xiao Y, Sicotte H, Decker PA, Kollmeyer TM, Hansen HM, Kosel ML, Zheng S, Walsh KM, Rice T and others. 2012. A low-frequency 8q24.21 variant is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH mutation. Nat Genet 44(10):1122-1125.
17. Kipp BR, Voss JS, Kerr SE, Barr Fritcher EG, Graham RP, Zhang L, Highsmith WE, Zhang J, Roberts LR, Gores GJ and others. 2012. Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma. Hum Pathol 43(10):1552-1558.
18. Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, Gilbert M, Aldape KD, Wei Q, Etzel C, Bondy ML. 2009. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 18(1):204-214.
19. Liu Y, Zhang H, Zhou K, Chen L, Xu Z, Zhong Y, Liu H, Li R, Shugart YY, Wei Q and others. 2007. Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis 28(9):1906-1913.
20. Liu Y, Zhou K, Zhang H, Shugart YY, Chen L, Xu Z, Zhong Y, Liu H, Jin L, Wei Q and others. 2008. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 29(3):381-389.
21. Malmer B, Adatto P, Armstrong G, Barnholtz-Sloan J, Bernstein JL, Claus E, Davis F, Houlston R, Il'yasova D, Jenkins R and others. 2007. GLIOGENE an international consortium to understand familial glioma. Cancer Epidemiol Biomarkers Prev 16(9):1730-1734.
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ and others. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559-575.
23. Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Chanock SJ and others. 2007. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 16(8):1655-1661.
24. Ruan Z, Zhao Y, Yan L, Chen H, Fan W, Chen J, Wu Q, Qian J, Zhang T, Zhou K and others. 2011. Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain glioma. Front Biosci (Elite Ed) 3:33-45.
25. Sanson M, Hosking FJ, Shete S, Zelenika D, Dobbins SE, Ma Y, Enciso-Mora V, Idbaih A, Delattre JY, Hoang-Xuan K and others. 2011. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 20(14):2897-2904.
26. Schwartzbaum J, Ahlbom A, Malmer B, Lonn S, Brookes AJ, Doss H, Debinski W, Henriksson R, Feychting M. 2005. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 65(14):6459-6465.
27. Schwartzbaum JA, Ahlbom A, Lonn S, Malmer B, Wigertz A, Auvinen A, Brookes AJ, Collatz Christensen H, Henriksson R, Johansen C and others. 2007. An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev 16(11):2448-2454.
28. Schwartzbaum JA, Xiao Y, Liu Y, Tsavachidis S, Berger MS, Bondy ML, Chang JS, Chang SM, Decker PA, Ding B and others. 2010. Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis 31(10):1770-1777.
29. Semmler A, Simon M, Moskau S, Linnebank M. 2006. The methionine synthase polymorphism c.2756A>G alters susceptibility to glioblastoma multiforme. Cancer Epidemiol Biomarkers Prev 15(11):2314-2316.
30. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY and others. 2009. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41(8):899-904.
31. Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K and others. 2011. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet 43(11):1098-1103.
32. Wang S, Zhao Y, Ruan Z, Chen H, Fan W, Chen J, Wu Q, Qian J, Zhang T, Huang Y and others. 2010. Association between EGF +61 G/A and glioma risk in a Chinese population. BMC Cancer 10(221):1-13.
33. Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY, Miike R, Wrensch M. 2007. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev 16(6):1229-1235.
34. Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R, Kelsey KT, Patoka J, Long J, Wrensch M. 2005. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev 14(7):1774-1783.
35. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. 1987. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84(19):6899-6903.
36. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S and others. 2009. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41(8):905-908.
37. Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, Sison JD, Aldape K, McMillan A, Wiemels J, Wiencke JK. 2005. ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol 7(4):495-507.
38. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ and others. 2009. IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765-773.
39. Yang P, Kollmeyer TM, Buckner K, Bamlet W, Ballman KV, Jenkins RB. 2005. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas. Cancer 103(11):2363-2372.